ResearcherUniversity of Naples Federico IIActive in the last 2 years
Roberto Ivan TROISI
Matched on ORCID iD 0000-0001-6280-810X; OpenAlex author ID A5041843585, A5111463322. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3↗
- A Systematic Review of Indications and Clinical Outcomes of Electrochemotherapy in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers17030408↗
- Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.01.016↗
- Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. Last author DOI 10.4251/wjgo.v15.i6.911↗
- Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e31829a80b7↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Gianluca Rompianesi · 1 shared paper, 2025 · strength 0.26
- Yoo‐Seok Yoon · 1 shared paper, 2023 · strength 0.19
- Fabrizio Panaro · 1 shared paper, 2023 · strength 0.19
- Gianluca Cassese · 1 shared paper, 2023 · strength 0.19
- Jun Suh Lee · 1 shared paper, 2023 · strength 0.19
- Ho‐Seong Han · 1 shared paper, 2023 · strength 0.19
- Boram Lee · 1 shared paper, 2023 · strength 0.19
- Vutha Ky · 1 shared paper, 2013 · strength 0.03
- Karen Paula Geboes · 1 shared paper, 2013 · strength 0.03
- Frederik Christiaan Berrevoet · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.